The DOI matches its OpenAlex record; 41 of the 41 references it cites were found in a registry or an index.
Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients
Open accessAbstract
Current theories of CF pathogenesis predict different predisposing "local environmental" conditions and sites of bacterial infection within CF airways. Here we show that, in CF patients with established lung disease, Pseudomonas aeruginosa was located within hypoxic mucopurulent masses in airway lumens. In vitro studies revealed that CF-specific increases in epithelial O(2) consumption, linked to increased airway surface liquid (ASL) volume absorption and mucus stasis, generated steep hypoxic gradients within thickened mucus on CF epithelial surfaces prior to infection. Motile P. aeruginosa deposited on CF airway surfaces penetrated into hypoxic mucus zones and responded to this environment with increased alginate production. With P. aeruginosa growth in oxygen restricted environments, local hypoxia was exacerbated and frank anaerobiosis, as detected in vivo, resulted. These studies indicate that novel therapies for CF include removal of hypoxic mucus plaques and antibiotics effective against P. aeruginosa adapted to anaerobic environments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matsui, H., Grubb, B. R., Tarran, R., Randell, S. H., Gatzy, J. T., Davis, C. W., & Boucher, R. C. (1998) · Cell · doi:10.1016/s0092-8674(00)81724-9 · Cited by 1,169
Self-citationCFTR as a cAMP-Dependent Regulator of Sodium Channels
Stutts, M. J., Canessa, C. M., Olsen, J. C., Hamrick, M., Cohn, J. A., Rossier, B. C., & Boucher, R. C. (1995) · Science · doi:10.1126/science.7543698 · Cited by 1,088
Self-citationMucus clearance as a primary innate defense mechanism for mammalian airways
Knowles, M. R., & Boucher, R. C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215217 · Cited by 1,054 · cited 1×
“Thus, we speculate that mucus clearance is a key feature of innate lung defense (44), and a fundamental defect leading to chronic CF lung infections is the failure to effectively clear mucus that contains bound bacteria from the lung (10).”
BackgroundSelf-citationCystic Fibrosis Airway Epithelia Fail to Kill Bacteria Because of Abnormal Airway Surface Fluid
Smith, J. J., Travis, S. M., Greenberg, E. P., & Welsh, M. J. (1996) · Cell · doi:10.1016/s0092-8674(00)81099-5 · Cited by 1,039
Davis, P. B., Drumm, M., & Konstan, M. W. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.5.8912731 · Cited by 764
Chromosomal genetics of Pseudomonas
Holloway, B. W., Krishnapillai, V., & Morgan, A. F. (1979) · Microbiological Reviews · doi:10.1128/mmbr.43.1.73-102.1979 · Cited by 761
Lam, J., Chan, R., Lam, K., & Costerton, J. W. (1980) · Infection and Immunity · doi:10.1128/iai.28.2.546-556.1980 · Cited by 649
Boucher, R. C., Stutts, M. J., Knowles, M. R., Cantley, L., & Gatzy, J. T. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112708 · Cited by 575
Self-citationRole of Mutant CFTR in Hypersusceptibility of Cystic Fibrosis Patients to Lung Infections
Pier, G. B., Grout, M., Zaidi, T. S., Olsen, J. C., Johnson, L. G., Yankaskas, J. R., & Goldberg, J. B. (1996) · Science · doi:10.1126/science.271.5245.64 · Cited by 440
Self-citationPrimarily nasal origin of exhaled nitric oxide and absence in Kartagener's syndrome
Lundberg, J., Weitzberg, E., Nordvall, S., Kuylenstierna, R., Lundberg, J., & Alving, K. (1994) · European Respiratory Journal · doi:10.1183/09031936.94.07081501 · Cited by 412
Research works printed but not linked: 6
- Meyer, 1993, J Lab Clin Med, 121, 654
- Zuelzer, 1949, Pediatrics, 4, 53, 10.1542/peds.4.1.53 · DOI
- Schidlow, 1994, Ann Allergy, 73, 457
- Jeffery, 1988, Scanning Microsc, 2, 553
- Stutts, 1985, Fed Proc, 44, 640
- Hohn, 1976, Surg Forum, 27, 18
Cited by
Bacterial biofilms: from the Natural environment to infectious diseases
Hall-Stoodley, L., Costerton, J. W., & Stoodley, P. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro821 · Cited by 7,143
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
Gibson, R. L., Burns, J. L., & Ramsey, B. W. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200304-505so · Cited by 1,633
Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence
Moradali, M. F., Ghods, S., & Rehm, B. H. A. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00039 · Cited by 1,537
The biofilm life cycle: expanding the conceptual model of biofilm formation
Sauer, K., Stoodley, P., Goeres, D. M., Hall-Stoodley, L., Burmølle, M., Stewart, P. S., & Bjarnsholt, T. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00767-0 · Cited by 1,404
Alveolar macrophages: plasticity in a tissue-specific context
Hussell, T., & Bell, T. J. (2014) · Nature Reviews Immunology · doi:10.1038/nri3600 · Cited by 1,377
Evolving concepts in biofilm infections
Hall-Stoodley, L., & Stoodley, P. (2009) · Cellular Microbiology · doi:10.1111/j.1462-5822.2009.01323.x · Cited by 1,136
Tolerance and resistance of microbial biofilms
Ciofu, O., Moser, C., Jensen, P. Ø., & Høiby, N. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00682-4 · Cited by 1,124
Bacterial Biofilm and its Role in the Pathogenesis of Disease
Vestby, L. K., Grønseth, T., Simm, R., & Nesse, L. L. (2020) · Antibiotics · doi:10.3390/antibiotics9020059 · Cited by 1,105
The role of bacterial biofilms in chronic infections
Bjarnsholt, T. (2013) · APMIS · doi:10.1111/apm.12099 · Cited by 1,080
The Microbiome and the Respiratory Tract
Dickson, R. P., Erb-Downward, J. R., Martinez, F. J., & Huffnagle, G. B. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105238 · Cited by 953
“Mucus production results in local pockets of anoxia (52) and increased temperature (53), both of which selectively favor the growth of certain community members.”
BackgroundThe clinical impact of bacterial biofilms
Høiby, N., Ciofu, O., Johansen, H. K., Song, Z., Moser, C., Jensen, P. Ø., Molin, S., Givskov, M., Tolker‐Nielsen, T., & Bjarnsholt, T. (2011) · International Journal of Oral Science · doi:10.4248/ijos11026 · Cited by 894
A Periciliary Brush Promotes the Lung Health by Separating the Mucus Layer from Airway Epithelia
Button, B., Cai, L.-H., Ehre, C., Kesimer, M., Hill, D. B., Sheehan, J. K., Boucher, R. C., & Rubinstein, M. (2012) · Science · doi:10.1126/science.1223012 · Cited by 863
Self-citationThe Changing Microbial Epidemiology in Cystic Fibrosis
LiPuma, J. J. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00068-09 · Cited by 806
Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients
Bjarnsholt, T., Jensen, P. Ø., Fiandaca, M. J., Pedersen, J., Hansen, C. R., Andersen, C. B., Pressler, T., Givskov, M., & Høiby, N. (2009) · Pediatric Pulmonology · doi:10.1002/ppul.21011 · Cited by 795
Bjarnsholt, T., Alhede, M., Alhede, M., Eickhardt-Sørensen, S. R., Moser, C., Kühl, M., Jensen, P. Ø., & Høiby, N. (2013) · Trends in Microbiology · doi:10.1016/j.tim.2013.06.002 · Cited by 764
Ciofu, O., & Tolker-Nielsen, T. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00913 · Cited by 720
Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective
Folkesson, A., Jelsbak, L., Yang, L., Johansen, H. K., Ciofu, O., Høiby, N., & Molin, S. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2907 · Cited by 715
Regulation of Immunity and Inflammation by Hypoxia in Immunological Niches
Taylor, C. T., & Colgan, S. P. (2017) · Nature reviews. Immunology · doi:10.1038/nri.2017.103 · Cited by 713
The role of pyocyanin in Pseudomonas aeruginosa infection
Lau, G. W., Hassett, D. J., Ran, H., & Kong, F. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.10.002 · Cited by 688
Nutritional Cues Control Pseudomonas aeruginosa Multicellular Behavior in Cystic Fibrosis Sputum
Palmer, K. L., Aye, L. M., & Whiteley, M. (2007) · Journal of Bacteriology · doi:10.1128/jb.01138-07 · Cited by 651
New concepts of the pathogenesis of cystic fibrosis lung disease
Boucher, R. C. (2004) · European Respiratory Journal · doi:10.1183/09031936.03.00057003 · Cited by 640
Self-citationBomberger, J. M., MacEachran, D. P., Coutermarsh, B. A., Ye, S., O'Toole, G. A., & Stanton, B. A. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000382 · Cited by 614
A dynamic and intricate regulatory network determines Pseudomonas aeruginosa virulence
Balasubramanian, D., Schneper, L., Kumari, H., & Mathee, K. (2013) · Nucleic Acids Research · doi:10.1093/nar/gks1039 · Cited by 591
Pseudomonas aeruginosa Anaerobic Respiration in Biofilms
Yoon, S. S., Hennigan, R. F., Hilliard, G. M., Ochsner, U. A., Parvatiyar, K., Kamani, M. C., Allen, H. L., DeKievit, T. R., Gardner, P. R., Schwab, U., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00295-2 · Cited by 585
Self-citationRatjen, F., Bell, S. C., Rowe, S. M., Goss, C. H., Quittner, A. L., & Bush, A. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.10 · Cited by 546
Pyoverdine siderophores: from biogenesis to biosignificance
Visca, P., Imperi, F., & Lamont, I. L. (2007) · Trends in Microbiology · doi:10.1016/j.tim.2006.11.004 · Cited by 544
Applying insights from biofilm biology to drug development — can a new approach be developed?
Bjarnsholt, T., Ciofu, O., Molin, S., Givskov, M., & Høiby, N. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4000 · Cited by 516
Airway Surface Dehydration in Cystic Fibrosis: Pathogenesis and Therapy
Boucher, R. C. (2007) · Annual Review of Medicine · doi:10.1146/annurev.med.58.071905.105316 · Cited by 512
Self-citationMicrobiome and Human Health: Current Understanding, Engineering, and Enabling Technologies
Aggarwal, N., Kitano, S., Puah, G. R. Y., Kittelmann, S., Hwang, I. Y., & Chang, M. W. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00431 · Cited by 508
Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense
Geiszt, M., Witta, J., Baff, J., Lekstrom, K., & Leto, T. L. (2003) · The FASEB Journal · doi:10.1096/fj.02-1104fje · Cited by 504
Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy
Cantin, A. M., Hartl, D., Konstan, M. W., & Chmiel, J. F. (2015) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2015.03.003 · Cited by 496
The role of the microbiome in exacerbations of chronic lung diseases
Dickson, R. P., Martinez, F. J., & Huffnagle, G. B. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61136-3 · Cited by 495
Oxygen Limitation Contributes to Antibiotic Tolerance of Pseudomonas aeruginosa in Biofilms
Borriello, G., Werner, E., Roe, F., Kim, A. M., Ehrlich, G. D., & Stewart, P. S. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2659-2664.2004 · Cited by 476
Detection of Anaerobic Bacteria in High Numbers in Sputum from Patients with Cystic Fibrosis
Tunney, M. M., Field, T. R., Moriarty, T. F., Patrick, S., Doering, G., Muhlebach, M. S., Wolfgang, M. C., Boucher, R., Gilpin, D. F., McDowell, A., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200708-1151oc · Cited by 468
Self-citationThe microbiome and critical illness
Dickson, R. P. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00427-0 · Cited by 460
Antibiotic treatment of biofilm infections
Ciofu, O., Rojo‐Molinero, E., Macià, M. D., & Oliver, A. (2017) · APMIS · doi:10.1111/apm.12673 · Cited by 422
Clinical Significance of Microbial Infection and Adaptation in Cystic Fibrosis
Hauser, A. R., Jain, M., Bar-Meir, M., & McColley, S. A. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-10 · Cited by 411
Jensen, P. Ø., Bjarnsholt, T., Phipps, R., Rasmussen, T. B., Calum, H., Christoffersen, L., Moser, C., Williams, P., Pressler, T., Givskov, M., et al. (2007) · Microbiology · doi:10.1099/mic.0.2006/003863-0 · Cited by 404
Moskowitz, S. M., Foster, J. M., Emerson, J., & Burns, J. L. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.5.1915-1922.2004 · Cited by 397
Ramsey, D. M., & Wozniak, D. J. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04552.x · Cited by 391
Pseudomonas aeruginosa adapts its iron uptake strategies in function of the type of infections
Cornelis, P., & Dingemans, J. (2013) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2013.00075 · Cited by 382
Cystic fibrosis lung environment and Pseudomonas aeruginosa infection
Bhagirath, A. Y., Li, Y., Somayajula, D., Dadashi, M., Badr, S., & Duan, K. (2016) · BMC Pulmonary Medicine · doi:10.1186/s12890-016-0339-5 · Cited by 378
An update on Pseudomonas aeruginosa biofilm formation, tolerance, and dispersal
Harmsen, M., Yang, L., Pamp, S. J., & Tolker-Nielsen, T. (2010) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2010.00690.x · Cited by 376
Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung
Sriramulu, D. D., Lünsdorf, H., Lam, J. S., & Römling, U. (2005) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45969-0 · Cited by 366
Physiology and pathophysiology of human airway mucus
Hill, D. B., Button, B., Rubinstein, M., & Boucher, R. C. (2022) · Physiological Reviews · doi:10.1152/physrev.00004.2021 · Cited by 366
Self-citationParallel bacterial evolution within multiple patients identifies candidate pathogenicity genes
Lieberman, T. D., Michel, J.-B., Aingaran, M., Potter-Bynoe, G., Roux, D., Davis, M. R., Skurnik, D., Leiby, N., LiPuma, J. J., Goldberg, J. B., et al. (2011) · Nature Genetics · doi:10.1038/ng.997 · Cited by 365
Towards diagnostic guidelines for biofilm-associated infections
Hall-Stoodley, L., Stoodley, P., Kathju, S., Høiby, N., Moser, C., William Costerton, J., Moter, A., & Bjarnsholt, T. (2012) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2012.00968.x · Cited by 357
Evidence for airway surface dehydration as the initiating event in CF airway disease
Boucher, R. C. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01744.x · Cited by 356
Self-citationDrewes, J. L., White, J. R., Dejea, C. M., Fathi, P., Iyadorai, T., Vadivelu, J., Roslani, A. C., Wick, E. C., Mongodin, E. F., Loke, M. F., et al. (2017) · npj Biofilms and Microbiomes · doi:10.1038/s41522-017-0040-3 · Cited by 335
Fodor, A. A., Klem, E. R., Gilpin, D. F., Elborn, J. S., Boucher, R. C., Tunney, M. M., & Wolfgang, M. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045001 · Cited by 353
Self-citationMicrobial ecology of the cystic fibrosis lung
Harrison, F. (2007) · Microbiology · doi:10.1099/mic.0.2006/004077-0 · Cited by 347
Effects of iron on DNA release and biofilm development by Pseudomonas aeruginosa
Yang, L., Barken, K. B., Skindersoe, M. E., Christensen, A. B., Givskov, M., & Tolker-Nielsen, T. (2007) · Microbiology · doi:10.1099/mic.0.2006/004911-0 · Cited by 347
Meers, P., Neville, M., Malinin, V., Scotto, A. W., Sardaryan, G., Kurumunda, R., Mackinson, C., James, G., Fisher, S., & Perkins, W. R. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn059 · Cited by 345
Taylor, P. K., Yeung, A. T. Y., & Hancock, R. E. W. (2014) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2014.09.003 · Cited by 340
Pseudomonas aeruginosa biofilm formation in the cystic fibrosis airway
Moreau-Marquis, S., Stanton, B. A., & O’Toole, G. A. (2008) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2007.12.001 · Cited by 335
Effective mucus clearance is essential for respiratory health
Randell, S. H., & Boucher, R. C. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0082sf · Cited by 335
Self-citationKahl, B. C., Becker, K., & Löffler, B. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00069-15 · Cited by 325
Bacterial Stress Responses during Host Infection
Fang, F. C., Frawley, E. R., Tapscott, T., & Vázquez-Torres, A. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.07.009 · Cited by 319
Gradients and consequences of heterogeneity in biofilms
Jo, J., Price-Whelan, A., & Dietrich, L. E. P. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00692-2 · Cited by 319
Rogers, G. B., Carroll, M. P., Serisier, D. J., Hockey, P. M., Jones, G., & Bruce, K. D. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.11.5176-5183.2004 · Cited by 318
Price-Whelan, A., Dietrich, L. E. P., & Newman, D. K. (2007) · Journal of Bacteriology · doi:10.1128/jb.00505-07 · Cited by 315
Mimicking biofilm formation and development: Recent progress in in vitro and in vivo biofilm models
Guzmán-Soto, I., McTiernan, C., Gonzalez-Gomez, M., Ross, A., Gupta, K., Suuronen, E. J., Mah, T.-F., Griffith, M., & Alarcon, E. I. (2021) · iScience · doi:10.1016/j.isci.2021.102443 · Cited by 309
Ciofu, O., Tolker-Nielsen, T., Jensen, P. Ø., Wang, H., & Høiby, N. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.11.017 · Cited by 306
Alvarez‐Ortega, C., & Harwood, C. S. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05772.x · Cited by 304
Early intervention and prevention of lung disease in cystic fibrosis: a European consensus
Döring, G., & Hoiby, N. (2004) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2004.03.008 · Cited by 304
Self-citationBacterial community morphogenesis is intimately linked to the intracellular redox state
Dietrich, L. E. P., Okegbe, C., Price-Whelan, A., Sakhtah, H., Hunter, R. C., & Newman, D. K. (2013) · Journal of Bacteriology · doi:10.1128/jb.02273-12 · Cited by 291
“Moreover, it is generally believed that in the organic-rich environment of infections—such as the mucus that collects on the lungs of individuals with cystic fibrosis— growth and survival of Pseudomonas is not carbon/electron limited but constrained by oxygen availability (30).”
BackgroundWilliamson, K. S., Richards, L. A., Perez-Osorio, A. C., Pitts, B., McInnerney, K., Stewart, P. S., & Franklin, M. J. (2012) · Journal of Bacteriology · doi:10.1128/jb.00022-12 · Cited by 289
P. aeruginosa Biofilms in CF Infection
Wagner, V. E., & Iglewski, B. H. (2008) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-008-8079-9 · Cited by 288
Redox Reactions of Phenazine Antibiotics with Ferric (Hydr)oxides and Molecular Oxygen
Wang, Y., & Newman, D. K. (2008) · Environmental Science & Technology · doi:10.1021/es702290a · Cited by 279
Sousa, A., & Pereira, M. (2014) · Pathogens · doi:10.3390/pathogens3030680 · Cited by 279
NTM drug discovery: status, gaps and the way forward
Wu, M.-L., Aziz, D. B., Dartois, V., & Dick, T. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.04.001 · Cited by 276
Antimicrobial Tolerance and Metabolic Adaptations in Microbial Biofilms
Crabbé, A., Jensen, P. Ø., Bjarnsholt, T., & Coenye, T. (2019) · Trends in Microbiology · doi:10.1016/j.tim.2019.05.003 · Cited by 276
Jiang, F., Waterfield, N. R., Yang, J., Yang, G., & Jin, Q. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.04.010 · Cited by 270
Desired Turbulence? Gut-Lung Axis, Immunity, and Lung Cancer
Bingula, R., Filaire, M., Radosevic-Robin, N., Bey, M., Berthon, J.-Y., Bernalier-Donadille, A., Vasson, M.-P., & Filaire, E. (2017) · Journal of Oncology · doi:10.1155/2017/5035371 · Cited by 270
Enhanced Pseudomonas aeruginosa Biofilm Development Mediated by Human Neutrophils
Walker, T. S., Tomlin, K. L., Worthen, G. S., Poch, K. R., Lieber, J. G., Saavedra, M. T., Fessler, M. B., Malcolm, K. C., Vasil, M. L., & Nick, J. A. (2005) · Infection and Immunity · doi:10.1128/iai.73.6.3693-3701.2005 · Cited by 263
Nitric oxide reductases of prokaryotes with emphasis on the respiratory, heme?copper oxidase type
ZUMFT, W. (2005) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2004.09.024 · Cited by 265
Eschbach, M., Schreiber, K., Trunk, K., Buer, J., Jahn, D., & Schobert, M. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.14.4596-4604.2004 · Cited by 264
Heijerman, H., Westerman, E., Conway, S., & Touw, D. (2009) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2009.04.005 · Cited by 264
Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung
Hogardt, M., & Heesemann, J. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2010.08.008 · Cited by 257
Goddard, A. F., Staudinger, B. J., Dowd, S. E., Joshi-Datar, A., Wolcott, R. D., Aitken, M. L., Fligner, C. L., & Singh, P. K. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107435109 · Cited by 256
Bragonzi, A., Paroni, M., Nonis, A., Cramer, N., Montanari, S., Rejman, J., Di Serio, C., Döring, G., & Tümmler, B. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200812-1943oc · Cited by 255
Self-citationChmiel, J. F., & Davis, P. B. (2003) · Respiratory Research · doi:10.1186/1465-9921-4-8 · Cited by 254
An overview of the pathogenesis of cystic fibrosis lung disease
Boucher, R. C. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00144-8 · Cited by 254
Self-citationEpidemiology, Biology, and Impact of Clonal Pseudomonas aeruginosa Infections in Cystic Fibrosis
Parkins, M. D., Somayaji, R., & Waters, V. J. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00019-18 · Cited by 253
PIER, G. (2007) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2007.03.012 · Cited by 253
Phenazine-1-carboxylic acid promotes bacterial biofilm development via ferrous iron acquisition
Wang, Y., Wilks, J. C., Danhorn, T., Ramos, I., Croal, L., & Newman, D. K. (2011) · Journal of Bacteriology · doi:10.1128/jb.00396-11 · Cited by 239
Role of Iron Uptake Systems in Pseudomonas aeruginosa Virulence and Airway Infection
Minandri, F., Imperi, F., Frangipani, E., Bonchi, C., Visaggio, D., Facchini, M., Pasquali, P., Bragonzi, A., & Visca, P. (2016) · Infection and Immunity · doi:10.1128/iai.00098-16 · Cited by 228
“aeruginosa grows mainly as dense, biofilm-like microcolonies in locally anoxic microenvironments (72).”
BackgroundHighly adherent small-colony variants of Pseudomonas aeruginosa in cystic fibrosis lung infection
Häußler, S., Ziegler, I., Löttel, A., Götz, F. V., Rohde, M., Wehmhöhner, D., Saravanamuthu, S., Tümmler, B., & Steinmetz, I. (2003) · Journal of Medical Microbiology · doi:10.1099/jmm.0.05069-0 · Cited by 228
Cystic Fibrosis Lung Disease: An Overview
Turcios, N. L. (2020) · Respiratory Care · doi:10.4187/respcare.06697 · Cited by 217
Yoon, S. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci24684 · Cited by 212
Ferrous Iron Is a Significant Component of Bioavailable Iron in Cystic Fibrosis Airways
Hunter, R. C., Asfour, F., Dingemans, J., Osuna, B. L., Samad, T., Malfroot, A., Cornelis, P., & Newman, D. K. (2013) · mBio · doi:10.1128/mbio.00557-13 · Cited by 173
Stewart, P. S., Zhang, T., Xu, R., Pitts, B., Walters, M. C., Roe, F., Kikhney, J., & Moter, A. (2016) · npj Biofilms and Microbiomes · doi:10.1038/npjbiofilms.2016.12 · Cited by 157
Sass, G., Nazik, H., Penner, J., Shah, H., Ansari, S. R., Clemons, K. V., Groleau, M.-C., Dietl, A.-M., Visca, P., Haas, H., et al. (2018) · Journal of Bacteriology · doi:10.1128/jb.00345-17 · Cited by 128
Quinn, R. A., Lim, Y. W., Maughan, H., Conrad, D., Rohwer, F., & Whiteson, K. L. (2014) · mBio · doi:10.1128/mbio.00956-13 · Cited by 115
A tale of two sites: how inflammation can reshape the microbiomes of the gut and lungs
Scales, B. S., Dickson, R. P., & Huffnagle, G. B. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3mr0316-106r · Cited by 109
“Direct in situ measurements of oxygen in CF sputum have confirmed that it ranges from microaerobic to anaerobic [53].”
BackgroundMarteyn, B., Scorza, F. B., Sansonetti, P. J., & Tang, C. (2011) · Cellular Microbiology · doi:10.1111/j.1462-5822.2010.01549.x · Cited by 102
Major, T. A., Panmanee, W., Mortensen, J. E., Gray, L. D., Hoglen, N., & Hassett, D. J. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00379-10 · Cited by 61
Caceres, S. M., Malcolm, K. C., Taylor-Cousar, J. L., Nichols, D. P., Saavedra, M. T., Bratton, D. L., Moskowitz, S. M., Burns, J. L., & Nick, J. A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03514-14 · Cited by 50
“However, surface attachment of bacterial microcolonies to the bronchial wall is not observed in vivo (11, 12).”
BackgroundInfluentialReighard, K. P., & Schoenfisch, M. H. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01208-15 · Cited by 49
Zygiel, E. M., Obisesan, A. O., Nelson, C. E., Oglesby, A. G., & Nolan, E. M. (2021) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.015975 · Cited by 36
Metadata
- Authors
- Worlitzsch, D., Tarran, R., Ulrich, M., Schwab, U. E., Cekici, A., Meyer, K. C., Birrer, P., Bellon, G., Berger, J., Weiß, T., Botzenhart, K., Yankaskas, J. R., Randell, S. H., Boucher, R. C., & Döring, G.
- Venue
- Journal of Clinical Investigation
- Published
- 2002-02-01
- Volume
- 109
- Issue
- 3
- Pages
- 317-325
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2121890764
- Cited by
- 1,099
- References
- 41
- FWCI
- 30.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.